1. Home
  2. CCEL vs PLSM Comparison

CCEL vs PLSM Comparison

Compare CCEL & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

HOLD

Current Price

$3.46

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

PLSM

Pulsenmore Ltd. Ordinary Shares

N/A

Current Price

$5.50

Market Cap

25.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCEL
PLSM
Founded
1989
2014
Country
United States
Israel
Employees
N/A
63
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
25.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CCEL
PLSM
Price
$3.46
$5.50
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.1K
1.8M
Earning Date
04-14-2026
03-30-2026
Dividend Yield
4.26%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$25,384,279.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$332.00
N/A
Revenue Growth
9.76
N/A
52 Week Low
$2.72
$3.00
52 Week High
$5.43
$12.97

Technical Indicators

Market Signals
Indicator
CCEL
PLSM
Relative Strength Index (RSI) 45.60 57.16
Support Level $3.11 $3.44
Resistance Level $3.92 $6.64
Average True Range (ATR) 0.26 1.06
MACD -0.05 0.21
Stochastic Oscillator 37.39 20.96

Price Performance

Historical Comparison
CCEL
PLSM

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About PLSM Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.

Share on Social Networks: